Sievert W - Search Results

1

Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways.

Hall SAL, Burns GS, Mooney BJ, Millen R, Morris R, Vogrin S, Sundararajan V, Ratnam D, Levy MT, Lubel JS, Nicoll AJ, Strasser SI, Sievert W, Desmond PV, Ngu MC, Angus P, Sinclair M, Meredith C, Matthews G, Revill PA, Jackson K, Littlejohn M, Bowden S, Locarnini SA, Thompson AJ, Visvanathan K. Hall SAL, et al. Among authors: sievert w. J Infect Dis. 2022 Dec 28;227(1):123-132. doi: 10.1093/infdis/jiac375. J Infect Dis. 2022. PMID: 36108079

2

Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection.

Pianko S, Patella S, Ostapowicz G, Desmond P, Sievert W. Pianko S, et al. Among authors: sievert w. J Viral Hepat. 2001 Nov;8(6):406-13. doi: 10.1046/j.1365-2893.2001.00316.x. J Viral Hepat. 2001. PMID: 11703571

3

Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection.

Danta M, Dore GJ, Hennessy L, Li Y, Vickers CR, Harley H, Ngu M, Reed W, Desmond PV, Sievert W, Farrell GC, Kaldor JM, Batey RG. Danta M, et al. Among authors: sievert w. Med J Aust. 2002 Sep 2;177(5):240-5. doi: 10.5694/j.1326-5377.2002.tb04755.x. Med J Aust. 2002. PMID: 12197817

4

Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.

Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM, Angus PW. Lubel JS, et al. Among authors: sievert w. Clin Sci (Lond). 2009 Sep 14;117(11):375-86. doi: 10.1042/CS20080647. Clin Sci (Lond). 2009. PMID: 19371232

5

Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B.

Patterson SJ, George J, Strasser SI, Lee AU, Sievert W, Nicoll AJ, Desmond PV, Roberts SK, Locarnini S, Bowden S, Angus PW. Patterson SJ, et al. Among authors: sievert w. Gut. 2011 Feb;60(2):247-54. doi: 10.1136/gut.2010.223206. Epub 2010 Oct 29. Gut. 2011. PMID: 21036792 Clinical Trial.

6

An argument for the universal prophylaxis of hepatitis B infection in patients receiving rituximab: a 7-year institutional experience of hepatitis screening.

Leung C, Tsoi E, Burns G, Sievert W. Leung C, et al. Among authors: sievert w. Oncologist. 2011;16(5):579-84. doi: 10.1634/theoncologist.2010-0182. Epub 2011 Apr 4. Oncologist. 2011. PMID: 21464465 Free PMC article.

7

IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection.

Holmes JA, Sievert W, Thompson AJ. Holmes JA, et al. Among authors: sievert w. Biomark Med. 2011 Aug;5(4):461-78. doi: 10.2217/bmm.11.47. Biomark Med. 2011. PMID: 21861668 Review.

8

Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.

Flynn JK, Dore GJ, Matthews G, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA; ATAHC Study Group. Flynn JK, et al. J Infect Dis. 2012 Nov 15;206(10):1568-76. doi: 10.1093/infdis/jis544. Epub 2012 Sep 4. J Infect Dis. 2012. PMID: 22949308 Free PMC article.

9

IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.

Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, Dev A, Bell S, Pianko S, Chen R, Visvanathan K, Hammond R, Iser D, Rusli F, Sievert W, Desmond PV, Bowden DS, Thompson AJ. Holmes JA, et al. Among authors: sievert w. J Gastroenterol Hepatol. 2013 May;28(5):861-6. doi: 10.1111/jgh.12110. J Gastroenterol Hepatol. 2013. PMID: 23301835

10

Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.

Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA; ATAHC Study Group. Flynn JK, et al. J Gastroenterol Hepatol. 2013 Nov;28(11):1770-81. doi: 10.1111/jgh.12265. J Gastroenterol Hepatol. 2013. PMID: 23663030 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters